Veru (VERU) Competitors $0.63 -0.03 (-3.83%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERU vs. NATR, MED, EL, IPAR, PBH, HLF, USNA, NUS, CKPT, and RZLTShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Nature's Sunshine Products (NATR), Medifast (MED), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Checkpoint Therapeutics (CKPT), and Rezolute (RZLT). Veru vs. Its Competitors Nature's Sunshine Products Medifast Estée Lauder Companies Inter Parfums Prestige Consumer Healthcare Herbalife USANA Health Sciences Nu Skin Enterprises Checkpoint Therapeutics Rezolute Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, community ranking, institutional ownership, analyst recommendations, dividends and risk. Do institutionals & insiders believe in VERU or NATR? 47.2% of Veru shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 14.9% of Veru shares are held by insiders. Comparatively, 4.7% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts prefer VERU or NATR? Veru presently has a consensus target price of $4.00, suggesting a potential upside of 536.94%. Nature's Sunshine Products has a consensus target price of $18.33, suggesting a potential upside of 26.05%. Given Veru's higher possible upside, equities research analysts plainly believe Veru is more favorable than Nature's Sunshine Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veru 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Nature's Sunshine Products 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer VERU or NATR? Veru received 104 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 69.82% of users gave Veru an outperform vote while only 64.02% of users gave Nature's Sunshine Products an outperform vote. CompanyUnderperformOutperformVeruOutperform Votes27369.82% Underperform Votes11830.18% Nature's Sunshine ProductsOutperform Votes16964.02% Underperform Votes9535.98% Which has preferable earnings & valuation, VERU or NATR? Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeru$16.89M5.45-$37.80M-$0.24-2.62Nature's Sunshine Products$456.62M0.58$15.08M$0.5327.44 Is VERU or NATR more profitable? Nature's Sunshine Products has a net margin of 3.81% compared to Veru's net margin of -223.85%. Nature's Sunshine Products' return on equity of 11.08% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets Veru-223.85% -112.75% -67.54% Nature's Sunshine Products 3.81%11.08%7.23% Does the media prefer VERU or NATR? In the previous week, Nature's Sunshine Products had 1 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 3 mentions for Veru. Veru's average media sentiment score of 1.29 beat Nature's Sunshine Products' score of 1.05 indicating that Veru is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veru 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nature's Sunshine Products 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, VERU or NATR? Veru has a beta of -0.8, indicating that its stock price is 180% less volatile than the S&P 500. Comparatively, Nature's Sunshine Products has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. SummaryNature's Sunshine Products beats Veru on 11 of the 17 factors compared between the two stocks. Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$92.06M$6.92B$5.61B$8.57BDividend YieldN/A2.54%5.28%4.17%P/E Ratio-2.428.6327.2219.81Price / Sales5.45265.57411.31154.51Price / CashN/A65.8538.3234.64Price / Book3.496.587.014.65Net Income-$37.80M$143.75M$3.23B$248.05M7 Day Performance1.62%1.52%-0.06%-0.15%1 Month Performance21.80%12.43%8.75%4.50%1 Year Performance-25.10%3.67%32.44%13.76% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru2.0173 of 5 stars$0.63-3.8%$4.00+536.9%-26.5%$92.06M$16.89M-2.42230Positive NewsNATRNature's Sunshine Products3.5402 of 5 stars$14.59+0.6%$18.33+25.7%-4.1%$267.74M$456.62M16.58850Positive NewsMEDMedifast3.7025 of 5 stars$13.27+4.5%$16.50+24.3%-36.5%$145.85M$543.45M73.72870ELEstée Lauder Companies3.9241 of 5 stars$69.05+0.9%$75.15+8.8%-38.6%$24.84B$14.79B-35.4163,000Positive NewsIPARInter Parfums3.5587 of 5 stars$138.53+0.4%$157.60+13.8%+23.9%$4.45B$1.47B29.73530Insider TradePBHPrestige Consumer Healthcare4.1592 of 5 stars$85.71+0.8%$93.33+8.9%+28.5%$4.24B$1.14B20.07540Positive NewsHLFHerbalife4.4906 of 5 stars$7.93+2.9%$11.50+45.1%-27.4%$807.34M$4.95B3.1810,100Positive NewsUSNAUSANA Health Sciences4.0427 of 5 stars$29.79+1.4%$36.00+20.8%-35.5%$554.82M$876.24M10.531,900NUSNu Skin Enterprises3.2669 of 5 stars$8.04+1.3%$6.88-14.4%-38.8%$397.08M$1.68B-2.7213,400Positive NewsCKPTCheckpoint Therapeutics2.5399 of 5 stars$4.26flat$4.33+1.7%N/A$370.71M$41K-2.3210RZLTRezolute2.7 of 5 stars$4.31-2.7%$11.83+174.6%-19.7%$368.59MN/A-3.5340Positive News Related Companies and Tools Related Companies NATR Alternatives MED Alternatives EL Alternatives IPAR Alternatives PBH Alternatives HLF Alternatives USNA Alternatives NUS Alternatives CKPT Alternatives RZLT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERU) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
